149,923 members

Skip to content. | Skip to navigation

News

First patient receives potential new treatment for wet age-related macular degeneration

* Join in to find members with similar interests, make connections, enlist on networks and start sharing information. It's useful and it's free.
 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

First patient receives potential new treatment for wet age-related macular degeneration

A pioneering trial of a new treatment derived from stem cells for people with ‘wet’ age-related macular degeneration (AMD) has commenced at Moorfields Eye Hospital following a successful operation on a patient.

This first operation is a major milestone in the London Project to Cure Blindness, which was established 10 years ago with the aim of curing vision loss in patients with wet AMD, and is the result of a partnership between the hospital, the UCL Institute of Ophthalmology, and the NIHR) Pfizer Inc. joined the partnership [in 2009] with the goal of helping to turn the original idea into a potential therapy.

The first surgery was successfully performed on a patient last month and there have been no complications to date. The patient wishes to remain anonymous, but the team hope to determine her outcome in terms of initial visual recovery by early December (2015).